Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

AMYT.L (AMYT) Share News

Amryt Pharma Reports Positive Results For Gene Therapy In Skin Disease

7th Jan 2019 09:41

LONDON (Alliance News) - Amryt Pharma PLC on Monday reported positive results from two pre-clinical studies of its novel non-viral gene therapy for recessive dystrophic epidermolysis company said Read More

Committee Recommends Adding More Patients To Amryt Pharma's Ease Trial

4th Jan 2019 13:32

LONDON (Alliance News) - Amryt Pharma PLC on Friday said an independent data monitoring committee has recommended adding more patients to its phase three Ease trial of epidermolysis bullosa drug a Read More

Amryt Pharma Secures Irish Government Grant To Develop AP103 Platform

10th Dec 2018 12:12

LONDON (Alliance News) - Amryt Pharma PLC on Monday said it has secured grant funding of EUR8.4 million over three years to develop its AP103 gene therapy platform.Amryt shares were trading Read More

Amryt Narrows Half Year Loss On Lojuxta Sales And Lower Expenses

26th Sep 2018 12:47

LONDON (Alliance News) - Oprhan drug company Amryt Pharma PLC said Wednesday its loss narrowed in the first half of 2018 due to increased sales of its rare disease drug Lojuxta and reduced the six Read More

Amryt Pharma Gets Rare Pediatric Disease Designation For AP101

2nd Aug 2018 12:15

LONDON (Alliance News) - Amryt Pharma PLC said Thursday that the US Food & Drug Administration has granted a rare pediatric disease designation for AP101, used for the treatment of Bullosa is Read More

Amryt Pharma Confident In 2018 With Strong First-Half Revenue Growth

19th Jul 2018 12:47

LONDON (Alliance News) - Amryt Pharma PLC said on Thursday it expects its performance for 2018 to be in line with current market expectations, following strong trading in the first half.The Read More

Amryt Pharma Gets NHS Approval For Cholesterol Drug Lojuxta

9th Jul 2018 10:46

LONDON (Alliance News) - Amryt Pharma PLC on Monday said its cholesterol reducing drug, Lojuxta, has been approved by the NHS in England.The pharmaceutical company, which focuses on rare in Read More

Amryt Pharma Gets Four Distribution Deals For Lojuxta In Middle East

29th May 2018 10:54

LONDON (Alliance News) - Amryt Pharma PLC on Tuesday said it signed four distribution deals for its cholesterol disorder drug Lojuxta across the Middle East.The biopharmaceutical company it Read More

Amryt Pharma Extends Lojuxta Licence Deal Into New Territories

10th May 2018 13:25

LONDON (Alliance News) - Amryt Pharma PLC on Thursday said it has expanded its Lojuxta licence agreement with Aegerion Pharmaceuticals Inc into Russia, the Commonwealth of Independent States, and Read More

Former Amryt Pharma Non-Executive Friel Sells 8.4 Million Shares (ALLISS)

8th May 2018 13:13

LONDON (Alliance News) - Amryt Pharma PLC on Tuesday said on Tuesday a company owned by a former non-executive director has sold 8.4 million shares in the company.Raglan Road Capital Ltd is Read More

Amryt 2017 Revenue Soars On Lojuxta Sales As New In-Licence Sealed

15th Mar 2018 14:15

LONDON (Alliance News) - Amryt Pharma PLC said Thursday it has signed an in-licence agreement for a gene therapy platform, with the company making a "very start in for to Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

8th Mar 2018 15:39

Friday 9 March SIGFull Year ResultsInmarsatFull Year ResultsGVC Year 12 Read More

Amryt Pharma Gets Positive Study Results For Possible Acromegaly Drug

6th Feb 2017 09:23

Amryt Pharma Plans Trials Of Episalvan Product By End Of 2016

9th Jun 2016 09:55

Amryt Pharma Starts Trading After Fastnet Reverse Takeover (ALLIPO)

19th Apr 2016 08:52

FTSE 100 Latest

Value8,585.01

Change-17.91